Formulation of meningitis vaccines

Details for Australian Patent Application No. 2008259423 (hide)

Owner Novartis AG

Inventors Contorni, Mario; Costantino, Paolo

Agent FB Rice

Pub. Number AU-A-2008259423

PCT Pub. Number WO2008/149238

Priority 60/933,235 04.06.07 US

Filing date 4 June 2008

Wipo publication date 11 December 2008

International Classifications

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 39/102 (2006.01) Medicinal preparations containing antigens or antibodies - Pasteurella

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/149238 Priority application(s): WO2008/149238

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008259426-Smoking article with novel wrappe

2008259421-Hybrid cable for conveying data and power